210
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience

, , , , &
Pages 883-892 | Received 12 Jan 2023, Accepted 30 May 2023, Published online: 09 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Benjian Gao, Fengyi Yang, Dongning Zheng, Shuai Hu, Jie Liu, Hong Liu, Yongfa Liu, LinXin Liu, Rui Wang, Yi Zhao, Cheng Cui, Cheng Fang, Jin Yang, Song Su, Yunwei Han, Xiaoli Yang & Bo Li. (2023) Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Journal of Hepatocellular Carcinoma 10, pages 2265-2276.
Read now